Real-World Evidence Uptake Is “Silver Lining” Of COVID-19 Response, USFDA’s Abernethy Says
The coronavirus pandemic highlights the work that is still needed on real-world evidence, agency's principal deputy commissioner says.
The coronavirus pandemic highlights the work that is still needed on real-world evidence, agency's principal deputy commissioner says.